EE400 Cost-Effectiveness of Cannabidiol (CBD) for the Treatment of Seizures in Patients with Treatment-Resistant Lennox-Gastaut Syndrome or Dravet Syndrome in the Netherlands

Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.666
https://www.valueinhealthjournal.com/article/S1098-3015(23)03796-8/fulltext
Section Title :
Section Order : 10149
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03796-8&doi=10.1016/j.jval.2023.09.666
HEOR Topics :
Tags :
Regions :